Experts are paying closer attention to medication reconciliation as a means to curb cost, but providers are finding the implementation isn't always easy.
Where plans and patients are spending the most money on medications.
A new report outlines the sharp cost increase associated with a NSCLC drug’s move from second-line to first-line treatment, and suggests payers work with manufacturers to address treatment pricing.
Several biosimilars will come to market within the next few years.
While most states have policies to evaluate premium increases, the Rate Review Program under the Patient Protection and Affordable Care Act (PPACA) puts a brighter spotlight on states' authority.
A new survey from Sage Growth Partners offers new ideas on executives’ application and adoption of telemedicine technology.
The contraceptive mandate stoked the legal fire of religious groups.
Lawyers are not expected to be technology experts, but they must be able to understand where relevant data exists and what steps must be taken to satisfy preservation and discovery obligations
Integrating programs that address social risk factors will improve health.
Market is expanding for government health IT contracts.
As the industry moves toward a retail environment, the importance of becoming member-centric can't be understated.
Lower courts will decide on the lingering concerns of uncertain PPACA provisions.
Smaller companies might offer innovation with a lower price tag, but they might not be able to achieve proper certification for incentives
Congressional authority is not the same as the authority given to a court of law
Cardiovascular disease (CVD) is underrecognized and undertreated in women, despite its prevalence
Congressional authority is not the same as the authority given to a court of law
Here are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions.
Unfortunately, many providers can't squeeze much more money out of cost reductions.
As the spiraling cost of healthcare continues to strain federal and state budgets, state Medicaid agencies are looking for powerful, workable solutions to the crisis.
A new study has eye-opening findings on the use of buprenorphine induction in an opioid-dependent population with commercial benefit coverage.
CMS will begin demonstration projects to further test the promise of P4P by bundling payments for certain services as single case-rates
There is a growing records management crisis in the world of healthcare. Hospitals are awash with paperwork, as legal, payer and regulatory requirements steadily generate an increasing number of documents per patient visit. Unfortunately, most healthcare information technology (HIT) systems are wholly inadequate to meet these growing documentation requirements.
Among large physician practices and acute care facilities, physicians and healthcare executives widely recognize the value of electronic medical records (EMRs). However, physicians at small or individual practices are just beginning to use the technology, noting high implementation costs as a deterrent.
Step into any newly designed hospital today and you just might do a double take. Lobbies, corridors and patient rooms look more like those in hotels these days, catering to patients and families with restaurant-like pagers, plush family seating that converts into beds and a menu of dining options that allows patients to order what they want and when.
In an interview with Managed Healthcare Executive, Christian T. Ruff, M.D., M.P.H., director of general cardiology at Brigham and Women's Hospital and associate professor at Harvard Medical School, addressed the uncertainty of the bleeding risks of abelacimab compared to rivaroxaban and highlighted abelacimab’s safety profile.
Hosptial program aligns high-cost clinical areas and financial strategies to realize benefits of the latest innovations
Hosptial program aligns high-cost clinical areas and financial strategies to realize benefits of the latest innovations
Hosptial program aligns high-cost clinical areas and financial strategies to realize benefits of the latest innovations
There are inherent challenges and opportunities for DM